W A Lagrèze. Show Affiliations »
Abstract
Mesh: See more » Adrenergic alpha-Agonists/therapeutic useAnimalsApoptosis/drug effectsApoptosis/physiologyBrimonidine TartrateClinical Trials as TopicDisease Models, AnimalDopamine Agents/therapeutic useEye Diseases/drug therapyEye Diseases/physiopathologyForecastingGlaucoma/drug therapyHumansMemantine/therapeutic useNeuroprotective Agents/therapeutic useOptic Neuritis/drug therapyQuinoxalines/therapeutic useRetinal Diseases/physiopathologyVisual Fields
Substances: See more » Adrenergic alpha-AgonistsDopamine AgentsNeuroprotective AgentsQuinoxalinesBrimonidine TartrateMemantine
Year: 2001 PMID: 11320808 DOI: 10.1007/s003470170154
Source DB: PubMed Journal: Ophthalmologe ISSN: 0941-293X Impact factor: 1.059